Van Maldergem syndrome 2 is a rare genetic condition that affects development of the face, ears, brain, and skeleton. Many people with Van Maldergem syndrome 2 have distinctive facial features and differences in the outer ears and hearing. Some also have developmental delay, low muscle tone, joint stiffness, and feeding or breathing difficulties in infancy. Van Maldergem syndrome 2 is lifelong, and features vary from mild to severe, but many children and adults can improve skills with early therapies. Care usually focuses on supportive treatments like hearing support, physical and speech therapy, seizure control if needed, and regular follow-up with specialists.
Overview
Van maldergem syndrome 2Symptoms
Van Maldergem syndrome 2 features developmental delay, low muscle tone, and feeding difficulties in infancy. Many have distinctive facial traits, joint laxity, ear and limb differences, hearing loss, and later speech and learning challenges; some show kidney or brain differences.
Outlook and prognosis
Many living with Van Maldergem syndrome 2 grow and learn at their own pace, with wide variation in abilities. Early therapies, hearing and vision support, and careful monitoring of breathing and feeding can improve comfort and independence. Lifespan depends on severity of features and complications, especially airway and developmental challenges.
Causes and risk factors
Van Maldergem syndrome 2 results from changes in the FAT4 gene and is inherited in an autosomal recessive pattern. Risk rises when parents are carriers, especially if related by blood. It begins before birth; environment and lifestyle don’t cause it.
Genetic influences
Genetics is central in Van Maldergem syndrome 2; it’s caused by inherited changes in specific genes. Most cases follow autosomal recessive inheritance, so parents are usually carriers without symptoms. Genetic testing confirms the diagnosis and informs family planning and recurrence risk.
Diagnosis
Clinicians suspect Van maldergem syndrome 2 from a pattern of facial, limb, and developmental features. Genetic diagnosis of Van maldergem syndrome 2 is confirmed by finding a disease‑causing variant on testing. Imaging, hearing/vision checks, and specialist exams help document findings.
Treatment and drugs
Treatment for Van Maldergem syndrome 2 focuses on supportive care tailored to each person’s needs. Teams often include pediatrics, genetics, orthopedics, ENT/audiology, ophthalmology, neurology, therapies, and dentistry, with hearing and vision support, seizure management, and surgeries for bone or airway issues as needed. Regular follow‑up helps adjust plans as children grow.
Symptoms
In infancy and early childhood, families often notice differences that affect feeding, movement, and growth. Early features of Van maldergem syndrome 2 often include distinctive facial traits, hand and joint differences, and developmental and speech delays. Features vary from person to person and can change over time. Hearing and vision differences, along with palate or dental issues, can shape how children learn, communicate, and move through daily routines.
Trouble latching or coordinating sucking and swallowing can lead to slow weight gain. Thickened feeds or special bottles may help, and feeding therapy is often useful.
Babies may feel floppy and take longer to hold up their head or sit. Low tone is common in Van maldergem syndrome 2 and can make early movement and posture take extra effort.
Rolling, sitting, walking, or fine hand skills may arrive later than expected. Thinking and problem-solving can also progress more slowly in Van maldergem syndrome 2.
First words may come later, and speech can sound unclear. Differences in hearing, palate shape, or muscle tone often contribute.
How people usually first notice Van maldergem syndrome 2?
Many families first notice Van Maldergem syndrome 2 soon after birth because a baby may have distinctive facial features, low muscle tone that makes feeding or latching difficult, or unusually flexible joints alongside stiff, bent fingers or toes. As infants grow, caregivers and doctors often pick up early developmental delays, limited speech, or hearing loss, and some babies are found to have hip or other joint dislocations during the first check-ups. In some cases, the first signs of Van Maldergem syndrome 2 also include differences seen on prenatal ultrasound or MRI, such as skeletal or ear anomalies.
Types of Van maldergem syndrome 2
Van Maldergem syndrome 2 is a rare genetic condition with a few recognized clinical variants that influence how features show up and how severe they are. Differences usually trace back to which gene is affected and the specific change within that gene. People may notice different sets of symptoms depending on their situation. When reading about types of Van Maldergem syndrome, you’ll often see the gene name used to label the variant.
DCHS1-related type
Changes in the DCHS1 gene are linked with the original form and can lead to distinctive facial features, joint laxity, and differences in ear shape. Developmental delay and speech challenges are common, and hearing loss can occur. Some may also have differences in the fingers or toes.
FAT4-related type
Variants in the FAT4 gene can cause a closely related presentation that overlaps but may include broader skeletal differences. This type sometimes shows more pronounced issues with joint stiffness and growth patterns. Care teams may monitor limb alignment and spine health more closely.
Within-gene variants
Different mutations within the same gene can shift severity from milder to more complex needs. Even within the same type, intensity can range from mild to severe. Families may notice that motor skills, speech, or hearing are affected to different degrees.
Spectrum with Hennekam
Some FAT4 changes sit on a spectrum that overlaps with Hennekam lymphangiectasia-lymphedema syndrome. This overlap can bring swelling of the limbs or face due to lymph flow differences. Not everyone will experience every type.
What genetics can tell you about symptoms
Some people with Van Maldergem syndrome 2 have DCHS1 gene changes that disrupt how cells stick and line up, leading to facial differences, wide-spaced eyes, and ear shape changes. These variations can also affect brain wiring and joints, causing developmental delays and flexible or unstable joints.
Causes and risk factors
Van Maldergem syndrome 2 is caused by harmful changes in the FAT4 gene, which helps guide early body development. Children are usually affected when they inherit one changed copy from each parent, known as autosomal recessive inheritance. Risk is higher when both parents are carriers, when there is a family history, or when the parents are related. Some risks are written in our DNA, passed down through families. There are no known lifestyle or environmental causes, though early care can shape how early symptoms of Van Maldergem syndrome 2 are recognized.
Environmental and biological risk factors
Van Maldergem syndrome 2 is present from birth, and many families ask about environmental risk factors for Van Maldergem syndrome 2 during pregnancy or early development. Doctors often group risks into internal (biological) and external (environmental). So far, studies have not identified specific environmental or pregnancy-related factors that change the likelihood of this condition. The points below summarize what is and isn’t known.
Current evidence does not show an increased chance of Van Maldergem syndrome 2 with older maternal age. Age-related risks seen with chromosomal conditions have not been shown for this condition.
Research to date has not demonstrated a clear link between older paternal age and this condition. Available data do not suggest a meaningful change in likelihood.
Health issues such as diabetes or thyroid disease can affect some pregnancies, but no consistent association with this syndrome has been found. Prenatal care remains important for overall pregnancy health.
Certain infections can disrupt fetal development, yet no specific infection has been tied to Van Maldergem syndrome 2. Routine infection prevention and vaccination guidance in pregnancy still applies.
Genetic risk factors
Van Maldergem syndrome 2 is driven by harmful changes in a single gene called DCHS1, usually inherited in an autosomal recessive pattern. In some cases, genetic testing can give a clearer picture of your personal risk. The genetic causes of Van Maldergem syndrome 2 involve getting two non-working copies—one from each parent—who are typically healthy carriers. Features can vary between individuals and even within the same family.
DCHS1 gene: Harmful changes in the DCHS1 gene disrupt how cells communicate during early development. When both copies are affected, Van Maldergem syndrome 2 can occur. Genetic testing can identify these changes.
Autosomal recessive: Van Maldergem syndrome 2 appears when a child inherits two faulty copies of DCHS1. Carrier parents usually have no symptoms. Each pregnancy has a 25% chance of being affected.
Carrier parents: Two carriers have a 25% chance for an affected child in each pregnancy. There is also a 50% chance a child will be a carrier like the parents. Family members may wish to consider carrier testing.
Family history: Having a sibling with Van Maldergem syndrome 2 increases the chance another child could be affected. Extended relatives may be carriers even if no one else has been diagnosed. A genetics clinic can map out the pattern.
Consanguinity: Parents who are related by blood are more likely to carry the same rare DCHS1 change. This raises the likelihood of an affected child in autosomal recessive conditions. Genetic counseling can explain personal risk.
Variant types: Disease-causing changes include missense variants that alter a protein building block and loss-of-function variants that stop the gene working. Different changes can contribute to differences in severity. Laboratories classify variants using well-established criteria.
Variable expression: Even with the same DCHS1 variants, features can vary in type and intensity. This variability is seen within and across families.
De novo variants: Rarely, one DCHS1 change may arise for the first time in the child while the other is inherited. This can explain Van Maldergem syndrome 2 without a clear family history. Parental testing can clarify the source.
Gene specificity: Van Maldergem syndrome 2 is linked to DCHS1 rather than FAT4. If testing shows FAT4 changes, that points to a different subtype of Van Maldergem syndrome. Knowing the exact gene helps with family counseling.
Lifestyle risk factors
Lifestyle habits do not cause Van Maldergem syndrome 2, but they can influence symptoms, day-to-day function, and complication risk. Focusing on nutrition, movement, sleep, and home-based therapies can support growth, motor skills, and breathing safety. Understanding how lifestyle affects Van Maldergem syndrome 2 helps families tailor routines that work alongside medical care.
Calorie-dense, texture-appropriate meals can improve growth despite oral–motor challenges. Working toward safe swallowing reduces aspiration risk during eating.
Daily gentle physiotherapy and low-impact play can strengthen core and stabilize lax joints. Avoiding high-impact or twisting activities may lower hip and knee injury risk.
Upright, well-supported seating during and after feeds helps protect the airway. This positioning can reduce choking and reflux that may complicate breathing.
Consistent bedtimes and side- or head-elevated sleeping (if advised) can ease snoring and sleep fragmentation linked to craniofacial features. Better sleep supports daytime attention and learning.
Risk prevention
For Van Maldergem syndrome 2, the genetic condition itself cannot be prevented, since it begins before birth. Prevention is about lowering risk, not eliminating it completely. The focus is on preventing complications, supporting development, and planning future pregnancies with informed choices. Because early symptoms of Van Maldergem syndrome 2 can be subtle, regular checks help catch issues early.
A genetics team can explain inheritance, offer carrier testing, and estimate recurrence risk. Options like prenatal testing or IVF with embryo testing may help in future pregnancies.
Scheduled visits with a pediatrician and specialists can spot problems early, when they’re easier to manage. This coordinated approach helps prevent avoidable complications.
Staying up to date with routine vaccines, including flu and pneumonia shots when advised, lowers the chance of serious infections. Fewer infections can reduce hospital stays and protect growth and development.
Early hearing tests and prompt treatment of middle-ear problems can prevent delays in speech and learning. Hearing aids or other supports may improve communication.
Transmission
Van Maldergem syndrome 2 is a genetic condition, not an infection, so it can’t be caught or spread through everyday contact. Most often, it happens when a child inherits two nonworking copies of the FAT4 gene—one from each parent—a pattern called autosomal recessive. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with Van Maldergem syndrome 2, a 50% chance the child will be a carrier like the parents, and a 25% chance of inheriting neither change. Carriers are typically healthy and may not know they carry a gene change; the chance of an affected child is higher when parents are blood relatives. Rarely, genetic transmission of Van Maldergem syndrome 2 can involve a new gene change, so genetic counseling can help families understand how Van Maldergem syndrome 2 is inherited and discuss testing options.
When to test your genes
Test your genes if you or your child show features suggesting Van Maldergem syndrome 2—such as distinctive facial shape, ear anomalies, developmental delay, or limb differences—or if a close relative is diagnosed. Genetic testing confirms the cause, guides care, and informs recurrence risk. Prenatal or preimplantation testing may be options after confirmation.
Diagnosis
For many families, the first clues are delayed milestones, feeding or speech difficulties, and noticeable ear or facial differences in a child. Doctors usually combine what they see in the clinic with imaging and genetic tests to evaluate Van Maldergem syndrome 2. Getting a diagnosis is often a turning point toward answers and support. When the pattern fits, genetic tests can confirm the condition and guide care for the child and the wider family, making the genetic diagnosis of Van Maldergem syndrome 2 clear.
Doctors look for a pattern of facial shape differences, unusual external ears, broad thumbs or toes, joint laxity, and possible hip problems. Seeing several of these features together raises suspicion for Van Maldergem syndrome 2. Documenting what’s present and what’s not helps narrow the possibilities.
Specialists assess motor skills, language, learning, and daily living abilities. Results highlight areas needing therapy and can signal when to add imaging or genetic tests. Tracking progress over time also helps judge treatment response.
Audiology tests check for hearing loss that can occur with ear structure differences. Early detection supports timely hearing aids or other interventions. This can improve speech and learning outcomes.
Imaging looks for clusters of nerve cells along the brain’s fluid spaces (called periventricular heterotopia) and other migration differences. These findings support the clinical impression and help distinguish the syndrome from other causes of developmental delay. MRI also screens for complications that may affect care.
Stages of Van maldergem syndrome 2
Van maldergem syndrome 2 does not have defined progression stages. It’s a genetic condition present from birth, and while features can vary from person to person, the course is generally stable rather than steadily worsening. Diagnosis typically relies on a careful exam, developmental history, and genetic testing, and early symptoms of Van maldergem syndrome 2 are often noticed in infancy or early childhood. Different tests may be suggested to help confirm the diagnosis and to check hearing, movement, or learning needs over time.
Outlook and prognosis
Looking at the long-term picture can be helpful. Many living with Van Maldergem syndrome 2 grow and learn at their own pace, often with a mix of developmental delays, distinctive facial features, and joint or skeletal differences that can affect mobility and daily tasks. Early care can make a real difference, especially when therapies start in infancy or early childhood to support feeding, speech, movement, and learning. Some people experience frequent ear infections, hearing loss, or breathing challenges due to airway shape, so regular check-ins with ENT and respiratory specialists matter. Heart or kidney differences are less common but may occur, and doctors usually screen for these early on.
The outlook is not the same for everyone, but many children with Van Maldergem syndrome 2 make steady gains with coordinated care and tailored education plans. Prognosis refers to how a condition tends to change or stabilize over time. Motor skills and communication can improve over years, though many will need ongoing therapies and adaptive tools. Life span is not well defined in published studies, but based on available reports, many individuals live into adolescence and adulthood, especially when breathing issues, feeding, and infections are well managed. Families often want to know how life will change, and for many, this can mean planning for long-term supports at school, at home, and in the community.
When thinking about the future, it helps to focus on practical steps: monitoring growth and nutrition; treating sleep-disordered breathing if present; addressing hearing and vision; and staying up to date with therapies. If you’re wondering about early symptoms of Van Maldergem syndrome 2 that may signal changing needs—such as new feeding struggles, snoring or pauses in breathing, or regression in skills—ask your care team how and when to check in. With ongoing care, many people maintain a stable health routine and continue to build skills over time. Talk with your doctor about what your personal outlook might look like, including plans for transition to adult services and supports.
Long-term effects
Van Maldergem syndrome 2 is a rare, genetic condition that tends to affect development of the brain, face, ears, limbs, and joints over time. Long-term effects vary widely, and day-to-day needs can look different from one person to another. Here’s what doctors and research know about the long-term effects of Van Maldergem syndrome 2, including how abilities and health can change from childhood into adulthood. The overall outlook depends on the mix and severity of features rather than any single finding.
Many have lifelong intellectual disability ranging from mild to moderate. School learning often progresses, but at a slower and more uneven pace.
Speech may be delayed and remain limited, with clearer understanding than expression. Some rely on alternative ways to communicate.
Ear shape differences and middle ear problems can lead to long-term conductive hearing loss. This can affect speech clarity and learning over time.
Low muscle tone and joint laxity can make walking and fine hand use slower to develop. Some continue to have clumsiness, fatigue with distance, or need mobility supports.
How is it to live with Van maldergem syndrome 2?
Living with Van Maldergem syndrome 2 often means navigating developmental delays, distinctive facial and skeletal features, and differences in hearing or joint mobility, with frequent visits to therapists and specialists woven into everyday routines. Many find that structured support—early intervention, speech and physical therapy, hearing support, and adaptive tools—helps children learn, communicate, and participate more fully at home and school. Families and caregivers usually become skilled coordinators, balancing appointments while celebrating steady, hard‑won progress, and friends or teachers may need clear guidance about how to support communication, learning pace, and mobility. With a consistent care plan and an inclusive environment, many grow into their strengths and build meaningful connections, even if milestones arrive on a different timeline.
Treatment and drugs
Treatment for Van maldergem syndrome 2 focuses on managing symptoms and supporting development over time, since there’s no single cure. Supportive care can make a real difference in how you feel day to day, often involving a team that may include pediatricians, geneticists, orthopedists, ear‑nose‑throat specialists, audiologists, eye doctors, dentists, and therapists. For many, this can mean early physical, occupational, and speech therapy; hearing support such as hearing aids if needed; vision care; dental and jaw care; and orthopedic interventions for joint or limb differences. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as pain relief for joint discomfort, antibiotics for ear or sinus infections, and sleep support if breathing issues disturb rest, while surgeries may be considered for structural concerns like airway obstruction or significant skeletal differences. Regular follow‑up helps adjust care as needs change, and genetic counseling can guide family planning and connect families with resources.
Non-drug treatment
Daily life with Van Maldergem syndrome 2 can involve movement delays, feeding challenges, hearing or vision differences, and learning needs that show up at home and school. Non-drug therapies aim to build skills, support communication, and keep joints, muscles, and breathing as healthy as possible. Alongside medicines, non-drug therapies can support day-to-day function and comfort. Plans are tailored to age, abilities, and family goals, and often change over time as needs evolve.
Targeted exercises can build strength, balance, and coordination to support sitting, standing, and walking. Stretching and positioning help prevent tight joints and hip problems.
Practice with hand skills and self-care tasks can make dressing, feeding, and play easier. Adaptive tools and splints can support hand function and independence.
Work on understanding and using language can improve communication at home and school. If speech is limited, picture boards or speech-generating devices can offer a reliable voice.
Swallow therapy focuses on safe chewing and drinking, especially if early symptoms of Van Maldergem syndrome 2 include feeding difficulties. Meal texture changes and positioning strategies can reduce choking and improve nutrition.
Your genes may have an impact on how drugs work for you
Medicines can act differently in people with Van Maldergem syndrome 2 because gene changes may alter how the body absorbs, breaks down, or responds to drugs. This means doses, side effects, and benefits might vary, so clinicians often individualize treatment.
Pharmacological treatments
There are currently no medications that change the underlying course of Van maldergem syndrome 2, so treatment focuses on easing day-to-day symptoms and protecting health. Drugs that target symptoms directly are called symptomatic treatments. Plans are tailored by pediatric, neurology, and rehab teams based on age, specific needs, and coexisting health issues. For some, this may start early to address feeding, reflux, sleep, or seizure concerns that show up among the early symptoms of Van maldergem syndrome 2.
Levetiracetam, valproate, or oxcarbazepine are often used if seizures occur. Choice depends on seizure type and side effects like sleepiness or mood changes. Not everyone responds to the same medication in the same way.
Oral baclofen or tizanidine can reduce tight muscles and ease stretching or positioning. Some may benefit from diazepam short term for spasms. Dosing may be increased or lowered gradually to find the lowest effective amount.
Omeprazole or lansoprazole can reduce stomach acid and protect the esophagus, especially with feeding difficulties. This may ease discomfort, vomiting, or irritability after meals.
Polyethylene glycol (PEG) or lactulose helps soften stools and reduce straining. Good hydration and fiber remain important alongside medicine.
Genetic influences
Van maldergem syndrome 2 is most often caused by changes in a single gene called FAT4, which helps guide how cells organize during early development. The condition follows an autosomal recessive pattern, meaning a child needs two nonworking copies—one from each parent—to be affected. A “carrier” means you have the gene change but may not show symptoms.
If both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child having Van maldergem syndrome 2, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance of neither. Features can vary widely, even among relatives with the same gene changes. Genetic testing for FAT4 and a discussion with a genetic counselor can help clarify whether Van maldergem syndrome 2 is inherited in your family and what the chances look like for future children.
Is Van maldergem syndrome 2 genetic?
Genetics is central in Van Maldergem syndrome 2; it’s caused by inherited changes in specific genes. Most cases follow autosomal recessive inheritance, so parents are usually carriers without symptoms. Genetic testing confirms the diagnosis and informs family planning and recurrence risk.
Pharmacogenetics—how genetics influence drug effects
For people living with Van Maldergem syndrome 2, care usually focuses on symptoms—hearing support, seizure control, pain relief, and safe anesthesia—rather than a single disease-specific drug. The gene change that causes Van Maldergem syndrome 2 helps confirm the diagnosis, but it does not yet point to a targeted medication or a unique dosing rule for the treatment of Van Maldergem syndrome 2. When medicines are needed, doctors use well-established guidance that applies broadly: some seizure drugs have known genetic safety cautions, and pain medicines like codeine or tramadol may work too strongly or not at all depending on how your body breaks them down. Alongside medical history and current medicines, genetic testing can add clues about drug response and help tailor choices or doses. This can be especially helpful if long-term anti-seizure therapy is planned, or if there have been unusual reactions to pain medicines or anesthesia in the past. Talk with your care team about whether pharmacogenetic testing could be useful before starting a new medicine, and always share any past side effects.
Interactions with other conditions
Ear, jaw, and airway differences in Van maldergem syndrome 2 can make colds, ear infections, or sleep apnea more likely, and these can in turn worsen hearing, speech progress, and daytime energy. Early symptoms of Van maldergem syndrome 2, like poor feeding and reflux, may interact with growth and lung health, especially if aspiration or frequent chest infections occur. Some conditions share “underlying mechanisms,” such as the overlap with a related lymphatic disorder (Hennekam syndrome), so clinicians may also check for limb or facial swelling and intestinal lymphatic issues that could affect nutrition and infection risk. If seizures are present, they can complicate learning and therapy schedules, and certain anti-seizure medicines may need to be balanced with treatments for reflux, constipation, or sleep problems. Skeletal features—like hip dysplasia or a curved spine—can interact with mobility limits and may increase pain or respiratory strain when another illness flares. These interactions vary widely, so care teams often coordinate ENT, neurology, cardiology, and rehabilitation input to reduce complications and support day-to-day function.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children born with unusual facial features, joint stiffness, and differences in learning and development, long before anyone knew the cause. Families sometimes recalled a cousin who needed help feeding as a baby or a sibling with very flexible joints who later had trouble with walking and speech. These everyday observations hinted at a pattern, but the pieces didn’t fit together until modern teams could compare detailed clinical notes and genetic findings across countries.
First described in the medical literature as a cluster of distinctive facial traits, limb differences, and developmental delay in several unrelated families, Van Maldergem syndrome 2 gradually took shape as its own condition. Early reports focused on what doctors could see and measure: newborn feeding challenges, low muscle tone, unusually placed ears, or bent fingers and toes. Over time, descriptions became more precise as clinicians noticed recurring features and tracked how children grew, learned, and required therapies through school years and into adulthood.
Advances in genetics helped explain why some families had more than one child with similar findings. Researchers discovered that changes in a gene involved in how cells organize their inner “scaffolding” could disrupt early development in many tissues at once. This insight connected the outward features with the underlying biology and confirmed that Van Maldergem syndrome 2 follows an autosomal recessive pattern—typically appearing when both parents carry one nonworking copy of the same gene.
Once considered rare, now recognized as a spectrum, the condition shows wide variation. Some people with Van Maldergem syndrome 2 have more noticeable facial traits and joint differences; others have subtler signs and are identified only after a younger relative is diagnosed. This variability explains why earlier case reports sometimes grouped different conditions together or missed milder forms. In recent decades, knowledge has built on a long tradition of observation, as clinical registries and international collaborations allowed teams to compare dozens of cases instead of a handful.
Today, the history of Van Maldergem syndrome 2 reflects the broader path of rare disease research: careful bedside observation, families’ shared experiences, and then the leap made possible by DNA testing. Looking back helps explain why some adults were never given a name for their symptoms, while children today can receive an earlier diagnosis, coordinated care, and clearer guidance for families planning future pregnancies.